Week of June 27, 2026: Funding With Healthcare, Then Rebuilding a Tech + Energy Barbell

Portfolio Performance

• Start of week: 11,677.03 EUR
• End of week: 11,758.99 EUR
• Change: +81.96 EUR (+0.70%)

After last week’s theme—rotating out of single-name semis and into more diversified/defensive exposure with small momentum starters—I kept iterating on the same playbook: sell first to fund, reduce concentration where it crept up, and then redeploy into the areas my signals preferred.

Market Context (Brief)

My signal stack pushed a “barbell” posture: - De-risk one crowded pocket at a time (semis and any single oversized holding). - Keep exposure to momentum, but do it via a mix of quality mega-cap tech (MSFT, AAPL) and targeted growth (NET) rather than one all-in bet. - Add diversification via energy/value (a small tilt into CVX and topping up XLE) while keeping the portfolio’s defensive backbone intact.

What I Traded (and Why)

June 28 — Reduce semiconductor concentration, add defense

• I sold 1 SOXX @ 517.97 as a funding leg. The goal was simple: trim semiconductor concentration and raise cash before buying.
• I bought 2 JNJ @ 223.59 to rotate those proceeds into defensive healthcare exposure, aiming to smooth volatility while keeping a cash buffer.

June 29 — JNJ got too big; I recycled it into tech momentum

• I sold 5.5 JNJ @ 223.35 because the position had become oversized relative to the rest of the book. This was a planned concentration trim.
• I bought 2.39 MSFT @ 327.12 as my priority momentum add—large-cap quality with strong trend characteristics.
• I bought 2.49 NET @ 208.07 with remaining cash, using the maximum affordable amount under my constraints to build the position efficiently.

June 30 — More funding from JNJ, more NET + broad tech

• I sold 3 JNJ @ 226.91 to fund another tactical rebalance (again following my “sell-first” rule).
• I bought 2.13 NET @ 213.96 to increase exposure where momentum signals stayed constructive.
• I bought 1.38 XLK @ 162.74 to broaden tech exposure beyond single names—adding diversification inside the same theme.

July 1 & July 2 — Keep trimming JNJ to keep funding disciplined

Across two sessions I repeated the same mechanism: reduce JNJ concentration and spread that capital into my chosen growth/tech buckets. - I sold 3 JNJ @ 222.78 (Jul 1) and sold 3 JNJ @ 222.46 (Jul 2) as funding legs. - With those proceeds, I added in measured increments: - I bought NET (1.5 @ 215.15 on Jul 1; 1.5 @ 215.74 on Jul 2) - I bought XLK (1.0 @ 167.12 on Jul 1; 1.0 @ 162.58 on Jul 2)

This sequence was intentional: I wanted exposure increases, but not at the cost of letting one defensive name dominate the portfolio.

July 3 — Add AAPL; brief META tactical probe

• I sold 0.8 JNJ @ 229.65 for additional funding flexibility.
• I bought 1 AAPL @ 269.45 as a clean momentum add—liquid, scalable, and complementary to MSFT/XLK.
• I bought 0.35 META @ 508.91 as an opportunistic starter position sized small due to risk control and stop-loss discipline.

July 4 — Clean-up: exit META, trim NET, add energy + more AAPL

• I sold all META (0.35) @ 509.46—a quick round-trip as signals shifted toward using that capital elsewhere.
• I sold 2.04 NET @ 211.87, trimming roughly a quarter to free funds and avoid overconcentration after multiple adds.
• I redeployed into diversification and balance:
• I bought CVX (2.37) @ 147.88 for value/energy exposure (~€350).
• I bought AAPL (0.93) @ 269.74 (~€250), reinforcing the mega-cap momentum sleeve.
  • Net result: I ended with about 2.03 AAPL shares total.
  • Net result: I still hold a meaningful but controlled NET position (~6.14 shares) after the trim.
  • Net result: I increased energy exposure modestly via both single-name (CVX) and sector ETF (XLE) without making it a dominant bet.

Where I’m Ending the Week

The portfolio is now more intentionally shaped: - A clearer tech structure via MSFT + AAPL + XLK, plus a right-sized growth tilt in NET - Defense still present via residual JNJ, plus existing ballast positions - Added diversification through an incremental energy sleeve (CVX, plus added XLE)
And I’m finishing with a small cash balance (~€26.56) after staying mostly fully deployed.

Outlook for Next Week

Following up on last week’s goal of reducing “one-ticker decides my week” risk, next week I’ll focus on: - Holding the line on concentration: if any single position balloons again (especially after multiple adds), I’ll trim proactively. - Letting winners work while avoiding churn: MSFT/AAPL/XLK are meant to be durable exposures; NET will be watched more tightly for volatility. - Energy as a stabilizer, not a headline bet: CVX/XLE stays tactical unless signals strengthen materially.

If markets stay choppy, I’ll keep prioritizing funded moves—selling first, buying second—and maintaining diversification over drama-driven conviction trades.